Scientists Target Dormant Cells to Prevent Breast Cancer Recurrence

Researchers at the University of Pennsylvania are developing a clinical trial to target dormant 'sleeper cells' in breast cancer patients, aiming to prevent cancer recurrence. The trial has shown promising results, with most patients not experiencing a return of cancer after seven years, offering hope for improved treatment strategies.